Dow up over 300 points as investors snap up beaten down stocks, S&P 500 nears all-time high – MarketWatch

Stocks stumbled in late trade Tuesday, giving up early gains as a selloff in tech shares continued and investors weighed the outlook for the economy amid a slowing in the number of new coronavirus cases and a lack of progress toward additional coronavirus aid from Washington.

The Dow Jones Industrial Average

was up 61.28 points, or 0.2%, to 27,852.72 after dipping into negative territory. The blue-chip gauge was up more than 300 points at its session high. The S&P 500

gave up an earlier gain to fall 8.39 points, or 0.3%, to 3,352.08. The tech-heavy Nasdaq Composite

dropped 118.37 points, or 1.1%, to 10,849.99.

The Russell 2000 Index

of small-capitalization companies outperformed, rising 4 points, or 0.3% at 1,589.

The Dow

on Monday rose 357.96 points, or 1.3%, to finish at 27,791.44, while the S&P 500

edged up 9.19 points, or 0.3%, to close at 3,360.47, just 0.8% away from its Feb. 19 record close of 3,386.15. The Nasdaq Composite
meanwhile, dropped 42.63 points, or 0.4%, ending at 10,968.36.

What’s driving the market?

Some analysts have been looking for a potentially sharp near-term rotation out of popular growth oriented stocks toward more cyclical shares once there were signs the worst of the pandemic was past and the economy could head toward a fuller reopening.

Read:Don’t assume this stock-market value rotation will stick, J.P. Morgan says

“In our central scenario, we expect no renewed nationwide lockdowns. Moderate restrictions on activity should be sufficient to keep outbreaks manageable, with a vaccine widely available from 2Q 2021,” said Mark Haefele, chief investment officer for global wealth management at UBS.

Combined with expansionary monetary policy and a moderate boost to fiscal stimulus, that would allow for a rebound in economic activity to pre-pandemic levels by 2022, he said, in a note. With yields anchored near record lows, the equity risk premium can normalize to pre-pandemic levels, allowing the S&P 500 to trade at 3,500 by the end of June 2021, Haefele said.

The Dow’s biggest gainers were JPMorgan Chase & Co.
American Express Co.

and Boeing Co.
while Apple Inc.

was its biggest drag, exemplifying the day’s shift away from soaring tech shares to stocks more tethered to economic performance.

“You’re starting to see a big catch up trade,” said Sam Hendel, president and co-portfolio manager at Levin Easterly Capital, in an interview, about the recent rally in equities away from the handful of technology companies that have led stock benchmarks higher, as the pandemic forced many white collar jobs to be done from home.

“Tech has really shined,” he said, but added that several catalysts, including optimism around an earnings recovery and the development and distribution of an effective vaccine, would benefit downtrodden stocks over the long run.

The number of new COVID-19 cases in the U.S. has fallen 18% over the past 14 days, according to a New York Times tracker, while deaths have fallen by 6%.

“In several key states (Arizona, California, Florida, Texas), hospital bed usage by COVID-19 patients is now clearly in decline. This is a critical trend that should limit further reopening reversals in the near-term,” wrote analysts at Macquarie, in a note.

They cautioned, however, that the latest model update from the Institute for Health Metrics and Evaluation at the University of Washington points to rising risks in the fall. It shows 26 states with a greater than 1 in 40 chance of breaching their intensive-care unit capacity by Nov. 1, up from 17 states previously. Another 12 states are at risk of doing so by Dec. 1, they noted.

Meanwhile, Thomas Barkin, president of the Richmond Federal Reserve, became the lasted Fed official to sound an alarm about the U.S. economy if Washington fails to produce another round of pandemic aid to beleaguered workers and businesses hammered by the coronavirus pandemic, saying that without the right stimulus, the economy could suffer a relapse.

Experts also reacted with alarm to Russia’s move to registered the world’s first COVID-19 vaccine without completing Phase 3 trials. The announcement marked a milestone in the race to find a vaccine against the disease, but also raised international concerns that Moscow had rushed the clinical evaluation of the treatment.

See: Russia’s accelerated COVID-19 vaccine greeted with alarm as experts say Phase 3 trial is essential

White House officials and top Democratic lawmakers on Monday indicated they were ready to resume talks on a coronavirus aid package after President Donald Trump over the weekend signed executive orders that would extend some elements of existing help that lapsed at the end of July, though there as little sign of movement. Trump’s orders, meanwhile, could face legal and logistical hurdles.

Investors, however, did appear to seize on Trump’s remark late Monday, in which he said the administration was considering a capital-gains tax cut.

“This is old news in a sense as Trump has floated this idea before, but markets may have taken it more seriously this time as the president seems eager to bypass the deadlocked Congress if he can,” said Marios Hadjikyriacos, investment analyst at XM, in a note.

The National Federation of Independent Business said its Small Business Optimism Index fell to 98.8 in July down 1.8 points from June. Economists surveyed by The Wall Street Journal expected a reading of 99.9.

The July producer-price index rose by 0.6% in July. Economists surveyed by MarketWach had forecast a rise of 0.3%. Core PPI, which strips out food and energy costs, rose 0.3%.

Which companies are in focus?
What are other markets doing?

In Asia trade, China’s CSI 300 index

fell 0.9%, while Hong Kong’s Hang Seng Index

rose 2.1% and Japan’s Nikkei 225 Index

advanced 1.9%.

In Europe, the pan-European Stoxx 600 Europe Index

and the FTSE 100

each rallied 1.7%.

The yield on the 10-year Treasury note

rose 7 basis points to 0.64% as investors shunned haven assets. Bond prices move inversely to yields.


retreated Tuesday from record territory, with December futures tumbling 4.6% to settle at $1,946.30 an ounce. Crude oil was flat, with U.S. benchmark futures

closed down 0.8% to settle at $41.61 a barrel.

The greenback was down 0.1%, with the ICE U.S. Dollar Index
a gauge of the buck against a half-dozen major rivals, at 93.63.